You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

TECZEM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Teczem, and what generic alternatives are available?

Teczem is a drug marketed by Biovail and is included in one NDA.

The generic ingredient in TECZEM is diltiazem malate; enalapril maleate. There are twenty-six drug master file entries for this compound. Additional details are available on the diltiazem malate; enalapril maleate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TECZEM?
  • What are the global sales for TECZEM?
  • What is Average Wholesale Price for TECZEM?
Summary for TECZEM
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:TECZEM at DailyMed
Drug patent expirations by year for TECZEM

US Patents and Regulatory Information for TECZEM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biovail TECZEM diltiazem malate; enalapril maleate TABLET, EXTENDED RELEASE;ORAL 020507-001 Oct 4, 1996 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TECZEM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Biovail TECZEM diltiazem malate; enalapril maleate TABLET, EXTENDED RELEASE;ORAL 020507-001 Oct 4, 1996 ⤷  Sign Up ⤷  Sign Up
Biovail TECZEM diltiazem malate; enalapril maleate TABLET, EXTENDED RELEASE;ORAL 020507-001 Oct 4, 1996 ⤷  Sign Up ⤷  Sign Up
Biovail TECZEM diltiazem malate; enalapril maleate TABLET, EXTENDED RELEASE;ORAL 020507-001 Oct 4, 1996 ⤷  Sign Up ⤷  Sign Up
Biovail TECZEM diltiazem malate; enalapril maleate TABLET, EXTENDED RELEASE;ORAL 020507-001 Oct 4, 1996 ⤷  Sign Up ⤷  Sign Up
Biovail TECZEM diltiazem malate; enalapril maleate TABLET, EXTENDED RELEASE;ORAL 020507-001 Oct 4, 1996 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for TECZEM

See the table below for patents covering TECZEM around the world.

Country Patent Number Title Estimated Expiration
Austria 54253 ⤷  Sign Up
New Zealand 192312 CARBOXYALKYL DIPEPTIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS ⤷  Sign Up
Canada 1262684 DERIVES AMINOACIDES ASSOCIES A DES AGENTS DIURETIQUES (AMINOACID DERIVATIVES COMPOSITION IN ASSOCIATION WITH DIURETIC AGENTS) ⤷  Sign Up
Canada 1275350 LISINOPRIL (LISINOPRIL) ⤷  Sign Up
Spain 8106134 ⤷  Sign Up
European Patent Office 0309051 CONTROLLED POROSITY OSMOTIC PUMP ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.